Johnson & Johnson or Procter & Gamble: If I Could Only Own 1 Dividend King for 20 Years, This Is It
Alpha Vantage · 24/7 Wall St. · · AI-summarised by FinFlash
This article compares Johnson & Johnson (JNJ) and Procter & Gamble (PG) as potential long-term dividend investments, both being Dividend Kings with similar valuations. The author concludes that J&J is the superior choice for a 20-year horizon due to better dividend coverage, anticipated double-digit earnings growth, and the absorption of major structural risks like biosimilar competition for Stelara.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.